Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).

For approximately 50 years after Sir James Paget first described the disease that now carries his name, the incidence of fracture as a complication of the disease was considered rare and received little attention. Since 1925, that view has changed, and it is believed that fractures in patients with Paget’s disease are common. Dickson et a1.I’ reported that pathologic fracture was the most frequent complication associated with Paget’s disease, an observation strongly supported by Lake” and Barry’ in subsequent reviews. In the last decade, promising therapy for Paget’s disease has become available in the

[1]  M. Hollander,et al.  Small-Sample Results for the Kaplan-Meier Estimator , 1982 .

[2]  P. Meunier,et al.  Use of etidronate (EHDP) in Paget's disease of bone. , 1980, Arthritis and rheumatism.

[3]  E. Siris,et al.  Long-term therapy of Paget's disease of bone with EHDP. , 1980, Arthritis and rheumatism.

[4]  F. Preston,et al.  EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASE , 1980, The Lancet.

[5]  E. Vignon,et al.  EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONE , 1979, The Lancet.

[6]  D. Verinder,et al.  The management of fractures in Paget's disease of bone. , 1979, Injury.

[7]  E. J. Stephens,et al.  Paget's disease of bone--clinical evaluation and treatment with diphosphonate. , 1979, Australian and New Zealand journal of medicine.

[8]  R. Altman,et al.  Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. , 1977, Annals of internal medicine.

[9]  H. Galbraith,et al.  Paget's disease of bone--a clinical and genetic study. , 1977, Postgraduate medical journal.

[10]  G. Finerman,et al.  Diphosphonate treatment of Paget's disease. , 1976, Clinical orthopaedics and related research.

[11]  C. Johnston,et al.  The loss of bone mineral with aging and its relationship to risk of fracture. , 1975, The Journal of clinical investigation.

[12]  R. Russell,et al.  Diphosphonates in Paget's disease. , 1974, Lancet.

[13]  R. Altman,et al.  Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). , 1973, The New England journal of medicine.

[14]  J. Erikson,et al.  Preparation of amine salts of thymolphthalein monophosphate and their use for measuring phosphatase activity. , 1973, Clinical chemistry.

[15]  J. Evans,et al.  Mithramycin in the treatment of Paget's disease of bone. , 1972, The Journal of bone and joint surgery. American volume.

[16]  F. Kolb,et al.  Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta. , 1972, JAMA.

[17]  D G Hoel,et al.  Statistical analysis of survival experiments. , 1972, Journal of the National Cancer Institute.

[18]  S. Wallach,et al.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone. , 1971, The Journal of clinical investigation.

[19]  P. Bordier,et al.  Human calcitonin in the treatment of Paget's bone disease. , 1971, Lancet.

[20]  F. Millard,et al.  Treatment of Paget's Disease of Bone with Mithramycin , 1971, British medical journal.

[21]  L. Avioli,et al.  Effects of prolonged thyrocalcitonin administration on Paget's disease of bone. , 1970, The New England journal of medicine.

[22]  A. Roy,et al.  Rapid method for determining alkaline phosphatase activity in serum with thymolphthalein monophosphate. , 1970, Clinical chemistry.

[23]  T. B. Schwartz,et al.  Effects of mithramycin on Paget's disease of bone. , 1969, Annals of internal medicine.

[24]  K. Kivirikko,et al.  Modifications of a specific assay for hydroxyproline in urine. , 1967, Analytical biochemistry.

[25]  S. A. Krane,et al.  Analysis of Survival Data by Regression Techniques , 1963 .

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  R. Weissenbach,et al.  [Treatment of Paget's disease of bone]. , 1953, Rhumatologie.

[28]  M. Lake Studies of Paget's disease (osteitis deformans). , 1951, The Journal of bone and joint surgery. British volume.

[29]  B. Maldague,et al.  [Roentgenologic Evaluation of the Action of the Diphosphonate Ehdp and of Combined Therapy (ehdp and Calcitonin) in Pagets-disease of Bone] , 1980 .

[30]  I. Stein,et al.  Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans. , 1977, Clinical orthopaedics and related research.

[31]  A. P. Iskrant,et al.  Osteoporosis in women 45 years and over related to subsequent fractures. , 1969, Public health reports.

[32]  M. J. Cohen,et al.  Osteitis Deformans (Paget's Disease of Bone). , 1926, Proceedings of the Royal Society of Medicine.

[33]  D.,et al.  Regression Models and Life-Tables , 2022 .